Taurine 7 pp 3-11 | Cite as

Effect of Taurine on Protein Kinase C Isoforms: Role in Taurine’s Actions?

  • Takashi Ito
  • Viktor Pastukh
  • Viktoriya Solodushko
  • Junichi Azuma
  • Stephen W. Schaffer
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 643)


Taurine is generally found to be cytoprotective, diminishing damage resulting from ischemia and from initiators of heart failure. Also linked to similar events in the heart is the protein kinase C (PKC) family, which consists of at least 12 different isoforms. Therefore, we proposed that PKC might contribute to the beneficial effects of taurine on cell viability and growth. One of the PKC isoforms that has been advanced as an important mediator of cytoprotection during ischemia is PKCϵ. In this study, we found that incubation of isolated cardiomyocytes with medium containing 20 mM taurine led to the translocation ofPKCϵ into the membrane, an event commonly associated with the cardioprotective actions of the PKC isozyme. In addition, taurine promoted the upregulation of PKCα PKCβ2 and PKCζ. Because the effects of taurine and angiotensin II on PKC distribution were largely additive, PKC does not appear to contribute to the antagonism between taurine and angiotensin II. However, the upregulation of PKC by taurine is consistent with a role of taurine in normal cell growth. In the taurine deficient heart, cardiomyocyte size is reduced, an effect that is consistent with the effect of taurine on PKCϵ. In conclusion, the cytoprotective and pro-growth actions of taurine appears to be mediated in part by the activation of PKCϵ.


Taurine Content Dietary Taurine Cardiomyopathic Hamster Cardiomyocyte Size Ischemic Precondi 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Azari J, Brumbaugh P, Huxtable R (1980) Prophylaxis by taurine in the hearts of cardiomyopathic hamsters. J Mol Cell Cardiol 12:1353–1366PubMedCrossRefGoogle Scholar
  2. Azuma J, Hasegawa H, Sawamura A, Awata N, Harada H, Ogura K, Kishimoto S (1982) Taurine for treatment of congestive heart failure. Int J Cardiol 2:303–304PubMedCrossRefGoogle Scholar
  3. Azuma M, Takahashi K, Fukuda T, Ohyabu Y, Yamamoto I, Kim S, Iwao H, Schaffer SW, Azuma J (2000) Taurine attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac myocytes. Eur J Pharmacol 403:181–188PubMedCrossRefGoogle Scholar
  4. Chapman RA, Suleiman MS, Earm YE (1993) Taurine and the heart. Cardiovasc Res 27:358–363PubMedCrossRefGoogle Scholar
  5. Chesney RW (1985) Taurine: its biological role and clinical implications. Adv Pediatr 32:1–42PubMedGoogle Scholar
  6. Churchill E, Budas G, Vallentin A, Koyanagi T, Mochly-Rosen D (2008) PKC isozymes in chronic cardiac disease: possible therapeutic targets? Annu Rev Pharmacol Toxicol 48:569–599PubMedCrossRefGoogle Scholar
  7. Dorn GW, 2nd, Force T (2005) Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115:527–537PubMedGoogle Scholar
  8. Gray MO, Karliner JS, Mochly-Rosen D (1997) A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 272:30945–30951PubMedCrossRefGoogle Scholar
  9. Hamaguchi T, Azuma J, Schaffer S (1991) Interaction of taurine with methionine: inhibition of myocardial phospholipid methyltransferase. J Cardiovasc Pharmacol 18:224–230PubMedCrossRefGoogle Scholar
  10. Harada H, Cusack BJ, Olson RD, Stroo W, Azuma J, Hamaguchi T, Schaffer SW (1990) Taurine deficiency and doxorubicin: interaction with the cardiac sarcolemmal calcium pump. Biochem Pharmacol 39:745–751PubMedCrossRefGoogle Scholar
  11. Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J (2008) Taurine depletion caused by knocking out the taurine transporter gene leads to a cardiomyopathy, muscle atrophy and mitochondrial dysfunction. J Mol Cell Cardiol 44(5):927–37PubMedCrossRefGoogle Scholar
  12. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, Anversa P (1997) Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 29:859–870PubMedCrossRefGoogle Scholar
  13. Liu GS, Cohen MV, Mochly-Rosen D, Downey JM (1999) Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 31: 1937–1948PubMedCrossRefGoogle Scholar
  14. McBroom MJ, Welty JD (1977) Effects of taurine on heart calcium in the cardiomyopathic hamster. J Mol Cell Cardiol 9:853–858PubMedCrossRefGoogle Scholar
  15. Newman WH, Frangakis CJ, Grosso DS, Bressler R (1977) A relation between myocardial taurine contest and pulmonary wedge pressure in dogs with heart failure. Physiol Chem Phys 9: 259–263PubMedGoogle Scholar
  16. Novotny MJ, Hogan PM, Flannigan G (1994) Echocardiographic evidence for myocardial failure induced by taurine deficiency in domestic cats. Can J Vet Res 58:6–12PubMedGoogle Scholar
  17. Novotny MJ, Hogan PM, Paley DM, Adams HR (1991) Systolic and diastolic dysfunction of the left ventricle induced by dietary taurine deficiency in cats. Am J Physiol 261:H121–H127Google Scholar
  18. Ohta H, Azuma J, Awata N, Hamaguchi T, Tanaka Y, Sawamura A, Kishimoto S, Sperelakis N (1988) Mechanism of the protective action of taurine against isoprenaline induced myocardial damage. Cardiovasc Res 22:407–413PubMedCrossRefGoogle Scholar
  19. Ping P, Zhang J, Pierce WM Jr, Bolli R (2001) Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ Res 88: 59–62PubMedCrossRefGoogle Scholar
  20. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, Bolli R (1997) Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81:404–414PubMedGoogle Scholar
  21. Pion PD, Kittleson MD, Rogers QR, Morris JG (1987) Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 237:764–768PubMedCrossRefGoogle Scholar
  22. Qi X, Inagaki K, Sobel RA, Mochly-Rosen D (2008) Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through J Clin Invest 118(1):173-82PubMedCrossRefGoogle Scholar
  23. Reinehr R, Becker S, Braun J, Eberle A, Grether-Beck S, Haussinger D (2006) Endosomal acidification and activation of NADPH oxidase isoforms are upstream events in hyperosmolarity-induced hepatocyte apoptosis. J Biol Chem 281:23150–23166PubMedCrossRefGoogle Scholar
  24. Ricci C, Pastukh V, Leonard J, Turrens J, Wilson G, Schaffer D, Schaffer SW (2008) Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. Am J Physiol Cell Physiol 294:C413–C422PubMedCrossRefGoogle Scholar
  25. Saurin AT, Pennington DJ, Raat NJ, Latchman DS, Owen MJ, Marber MS (2002) Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res 55: 672–680PubMedCrossRefGoogle Scholar
  26. Schaffer S, Solodushko V, Pastukh V, Ricci C, Azuma J (2003) Possible Cause of Taurine-deficient Cardiomyopathy: Potentiation of Angiotensin II Action. J Cardiovasc Pharmacol 41:751–759PubMedCrossRefGoogle Scholar
  27. Schaffer SW, Lombardini JB, Azuma J (2000) Interaction between the actions of taurine and angiotensin II. Amino Acids 18:305–318PubMedCrossRefGoogle Scholar
  28. Takahashi K, Azuma M, Taira K, Baba A, Yamamoto I, Schaffer SW, Azuma J (1997) Effect of taurine on angiotensin II-induced hypertrophy of neonatal rat cardiac cells. J Cardiovasc Pharmacol 30:725–730PubMedCrossRefGoogle Scholar
  29. Takahashi K, Ohyabu Y, Solodushko V, Takatani T, Itoh T, Schaffer SW, Azuma J (2003) Taurine renders the cell resistant to ischemia-induced injury in cultured neonatal rat cardiomyocytes. J Cardiovasc Pharmacol 41:726–733PubMedCrossRefGoogle Scholar
  30. Takihara K, Azuma J, Awata N, Ohta H, Hamaguchi T, Sawamura A, Tanaka Y, Kishimoto S, Sperelakis N (1986) Beneficial effect of taurine in rabbits with chronic congestive heart failure. Am Heart J 112(6):1278-84PubMedCrossRefGoogle Scholar
  31. Zhuang S, Hirai SI, Ohno S (2000) Hyperosmolality induces activation of cPKC and nPKC, a requirement for ERK1/2 activation in NIH/3T3 cells. Am J Physiol Cell Physiol 278: C102–C109PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Takashi Ito
    • 1
  • Viktor Pastukh
  • Viktoriya Solodushko
  • Junichi Azuma
  • Stephen W. Schaffer
  1. 1.Department of PharmacologyUniversity of South Alabama College of MedicineUSA

Personalised recommendations